Leukemia
Knocking Out Survival Protein Could Aid Leukemia Treatment
Published in Cancer Weekly, May 8th, 2007
The findings suggest that a drug that can block this “survival protein” might on its own be an effective therapy.
But such a drug used in combination with several existing drugs might also offer an effective one-two punch against drug-resistant forms of chronic lymphocytic leukemia (CLL) and acute lymphoblastic leukemia (ALL). The two forms of cancer kill about 20,500 Americans yearly.
The survival protein is called Mcl1. It usually helps keep normal cells healthy and is involved in the development...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2007-05-08)
More Articles from Cancer Weekly
- Gene Therapy
UHN Receives Second $10 Million Gift to Support McEwen Centre for Regenerative Medicine - Anemia
Aranesp "145 Study'' Shows No Difference in Survival in Patients with Small-Cell Lung Cancer - Bladder Cancer
Imalux Announces Major European Clinical Trials - Breast Cancer
Breast Cancer Incidence Continues to Trend Low in 2004; Decline Supports Role of HRT - Breast Cancer
Casting for Recovery (CFR) to Participate in Rose Festival's Centennial Grand Floral Parade - Breast Cancer
Celera and LabCorp Announce Licensing Agreement to Commercialize Breast Cancer Testing Assays - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
